Safety Study of Post Tonsillectomy Ibuprofen Use in Adults

This study is currently recruiting participants. (see Contacts and Locations)
Verified April 2013 by Brooke Army Medical Center
Sponsor:
Collaborators:
Madigan Army Medical Center
Tripler Army Medical Center
Wilford Hall Medical Center
Blanchfield Army Community Hospital
Information provided by (Responsible Party):
Gregory R. Dion, Brooke Army Medical Center
ClinicalTrials.gov Identifier:
NCT01837810
First received: April 18, 2013
Last updated: April 22, 2013
Last verified: April 2013
  Purpose

The purpose of this study is to determine if ibuprofen use after electrocautery tonsillectomy increases the post-tonsillectomy hemorrhage rate.

Hypothesis: Use of ibuprofen does not increase the post-tonsillectomy hemorrhage rate.

Primary outcome: Rate of tonsillar hemorrhage following adult tonsillectomy in those receiving narcotic pain medications plus ibuprofen compared to those receiving narcotics alone.

Secondary outcome: Determine whether ibuprofen, a non-steroidal anti-inflammatory drug (NSAID), decreases post tonsillectomy pain, narcotic pain medication use, or cost of pain management.


Condition Intervention
Secondary Post Tonsillectomy Hemorrhage
Primary Post Tonsillectomy Hemorrhage
Drug: Ibuprofen

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double Blind (Subject, Caregiver, Investigator)
Primary Purpose: Supportive Care
Official Title: NSAID Post-Tonsillectomy Hemorrhage: A Randomized, Double-Blinded Controlled Noninferiority Trial

Resource links provided by NLM:


Further study details as provided by Brooke Army Medical Center:

Primary Outcome Measures:
  • clinically defined tonsil bleed rate (percentage) [ Time Frame: 2 weeks ] [ Designated as safety issue: Yes ]
    A post tonsillectomy hemorrhage/bleed, for the purposes of this study, is defined as a postoperative bleed requiring anything more than medicinal intervention (cauterization of any kind, suture, evaluation in operating room).


Secondary Outcome Measures:
  • Hospital readmission rate (percentage) [ Time Frame: 2 weeks ] [ Designated as safety issue: No ]
  • Subclinical (not requiring intervention) subjectively reported tonsil bleed rate (percentage) [ Time Frame: 2 weeks ] [ Designated as safety issue: No ]
    Subjects will report on followup survey if they had post operative oral bleeding more than streaked blood in their spit for which they did not go to the hospital or clinic for treatment of.

  • Pain scale rating [ Time Frame: 2 Weeks ] [ Designated as safety issue: No ]
    Subjects will answer a visual analog scale (VAS) Pain scale for days 1, 3, 7, and 14 after tonsillectomy.

  • Nausea Scale [ Time Frame: 2 weeks ] [ Designated as safety issue: No ]
    Subjects will answer a VAS nausea scale for days 1, 3, and 7 after tonsillectomy.


Estimated Enrollment: 810
Study Start Date: April 2013
Estimated Study Completion Date: May 2016
Estimated Primary Completion Date: April 2016 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Ibuprofen
800mg ibuprofen every 8 hours prn pain.
Drug: Ibuprofen
800mg every 8 hours as needed for pain
Other Names:
  • ibuprofen
  • Advil
  • Motrin
Placebo Comparator: Methylcellulose Powder
Subjects receive inert methylcellulose powder as placebo

Detailed Description:

Tonsillectomy is common procedure associated with significant post-operative pain typically managed by narcotic pain medication. Narcotics, however, can have inherent unwanted side effects such as respiratory depression. In fact, a recent U.S. Food and Drug Administration (FDA) warning has reported deaths from respiratory distress that were associated with use of codeine in children after tonsillectomy. Finding alternative pain management regimens therefore is essential in post-tonsillectomy care. Non-steroidal anti-inflammatory (NSAID) medications may provide an effective alternative to narcotics, but use of NSAIDs routinely after tonsillectomy has been limited due to concern for theoretical increased risk of post-operative bleeding, This is likely true for NSAIDs such as aspirin. NSAIDs such as ibuprofen, however, are believed to have no greater risk of bleeding than baseline, but this has not been proven. Recent, well-designed, prospective pediatric studies have demonstrated effective analgesia improvement with the addition of non-steroidal anti-inflammatory drugs such as ibuprofen to post-operative pain management regimens, and no increased rate of post-surgery bleeding. This has not adequately been studied in adults but could provide many patients significant pain relief in the post-operative period if it is shown to not increase post tonsillectomy hemorrhage rates, as already demonstrated in the pediatric population.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Adults 18 years old or older
  • Scheduled for tonsillectomy

Exclusion Criteria:

  • Prisoners
  • Pregnancy
  • Allergy to ibuprofen
  • History of vasculopathy to include Lupus or Wegener's or Disseminated Intravascular Coagulation (DIC)
  • Any other bleeding disorder to include Von Willebrand Disease and others
  • Active Neoplasm of any kind
  • Tonsillectomy in combination with any sleep surgical procedure or palatal procedure
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01837810

Contacts
Contact: Gregory R Dion, MD, MS 210-916-8040 gregory.r.dion.mil@mail.mil
Contact: Thomas J Willson, MD 210-916-2367 thomas.j.willson.mil@mail.mil

Locations
United States, Texas
Brooke Army Medical Center Recruiting
Fort Sam Houston, Texas, United States, 78234
Contact: Gregory R Dion, MD, MS    210-916-8040    gregory.r.dion.mil@mail.mil   
Principal Investigator: Gregory R Dion, MD, MS         
Wilford Hall Ambulatory Surgical Center Not yet recruiting
Lackland AFB, Texas, United States, 78236
Contact: Thomas J Willson, MD    210-916-2367    thomas.j.willson.mil@mail.mil   
Principal Investigator: Thomas J Willson, MD         
United States, Washington
Madigan Army Medical Center Not yet recruiting
Tacoma, Washington, United States, 98431
Contact: Del R Sloneker, MD    253-968-1420    del.r.sloneker.mil@mail.mil   
Principal Investigator: Del R Sloneker, MD         
Sponsors and Collaborators
Brooke Army Medical Center
Madigan Army Medical Center
Tripler Army Medical Center
Wilford Hall Medical Center
Blanchfield Army Community Hospital
Investigators
Principal Investigator: Gregory R Dion, MD, MS San Antonio Military Medical Center
  More Information

No publications provided

Responsible Party: Gregory R. Dion, MD, MS, CPT, MC, USA, Brooke Army Medical Center
ClinicalTrials.gov Identifier: NCT01837810     History of Changes
Other Study ID Numbers: 384409
Study First Received: April 18, 2013
Last Updated: April 22, 2013
Health Authority: United States: Institutional Review Board
United States: Federal Government

Keywords provided by Brooke Army Medical Center:
Post tonsillectomy hemorrhage
post operative hemorrhage
complications
tonsillectomy

Additional relevant MeSH terms:
Hemorrhage
Pathologic Processes
Ibuprofen
Anti-Inflammatory Agents, Non-Steroidal
Analgesics, Non-Narcotic
Analgesics
Sensory System Agents
Peripheral Nervous System Agents
Physiological Effects of Drugs
Pharmacologic Actions
Anti-Inflammatory Agents
Therapeutic Uses
Antirheumatic Agents
Cyclooxygenase Inhibitors
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Central Nervous System Agents

ClinicalTrials.gov processed this record on August 20, 2014